nyvepria

Generic: pegfilgrastim-apgf

Labeler: pfizer laboratories div pfizer inc
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name nyvepria
Generic Name pegfilgrastim-apgf
Labeler pfizer laboratories div pfizer inc
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

pegfilgrastim 6 mg/.6mL

Manufacturer
Pfizer Laboratories Div Pfizer Inc

Identifiers & Regulatory

Product NDC 0069-0324
Product ID 0069-0324_a89f35d2-46e6-457b-a617-3c7537e6f709
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761111
Listing Expiration 2026-12-31
Marketing Start 2020-12-15

Pharmacologic Class

Established (EPC)
leukocyte growth factor [epc]
Chemical Structure
granulocyte colony-stimulating factor [cs]
Physiologic Effect
increased myeloid cell production [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00690324
Hyphenated Format 0069-0324

Supplemental Identifiers

RxCUI
2469335 2469340
UNII
3A58010674
NUI
M0024696 N0000009451 N0000175666

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name nyvepria (source: ndc)
Generic Name pegfilgrastim-apgf (source: ndc)
Application Number BLA761111 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 6 mg/.6mL
source: ndc
Packaging
  • 1 CARTON in 1 CARTON (0069-0324-01) / 1 SYRINGE in 1 CARTON / .6 mL in 1 SYRINGE
source: ndc

Packages (1)

Ingredients (1)

pegfilgrastim (6 mg/.6mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "a89f35d2-46e6-457b-a617-3c7537e6f709", "openfda": {"nui": ["M0024696", "N0000009451", "N0000175666"], "unii": ["3A58010674"], "rxcui": ["2469335", "2469340"], "spl_set_id": ["99d30b99-2743-446b-98f3-0430bf4ea869"], "pharm_class_cs": ["Granulocyte Colony-Stimulating Factor [CS]"], "pharm_class_pe": ["Increased Myeloid Cell Production [PE]"], "pharm_class_epc": ["Leukocyte Growth Factor [EPC]"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 CARTON in 1 CARTON (0069-0324-01)  / 1 SYRINGE in 1 CARTON / .6 mL in 1 SYRINGE", "package_ndc": "0069-0324-01", "marketing_start_date": "20201215"}], "brand_name": "NYVEPRIA", "product_id": "0069-0324_a89f35d2-46e6-457b-a617-3c7537e6f709", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Granulocyte Colony-Stimulating Factor [CS]", "Granulocyte-Macrophage Colony-Stimulating Factor [CS]", "Increased Myeloid Cell Production [PE]", "Leukocyte Growth Factor [EPC]"], "product_ndc": "0069-0324", "generic_name": "pegfilgrastim-apgf", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NYVEPRIA", "active_ingredients": [{"name": "PEGFILGRASTIM", "strength": "6 mg/.6mL"}], "application_number": "BLA761111", "marketing_category": "BLA", "marketing_start_date": "20201215", "listing_expiration_date": "20261231"}